As demonstrated in Fig. 9, MED8 showed increased expression levels, while KPNA2 and YBX1 showed dramatically decreased expression levels in the liver of mice with NAFLD. This evidence concerns the gene KPNA2 and metabolic dysfunction-associated steatotic liver disease.